GlassScriptPhysician profile
Omer Munshi
NPI 1790913739
$755.80
in general payments reported to CMS, 2019-2025
16 companies · $52.91 in 2025
The $52.91 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $74.73 · 2021: $159 · 2022: $57.00 · 2023: $110 · 2024: $22.85 · 2025: $52.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $185.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $171.78 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.50 | 2019-2022 | |
| Janssen Biotech, INC. | $73.92 | 2019 | |
| Stryker Corporation | $71.14 | 2019 | |
| Nevro Corp. | $56.88 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $45.10 | 2021 | |
| Medtronic USA, INC. | $37.30 | 2019-2020 | |
| Globus Medical, INC. | $36.76 | 2025 | Senza |
| Stimwave Technologies Incorporated | $35.28 | 2019 | |
| Lilly USA, LLC | $32.17 | 2019-2021 | |
| Almatica Pharma LLC | $26.54 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.98 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $18.23 | 2021 | |
| Grt US Holding, INC. | $17.05 | 2022 | |
| Avanos Medical | $16.15 | 2025 | Standard Rf Disposables |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $14.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omer Munshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.